Related Experiment Video
Updated: Aug 5, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
Hippo-YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas
Ernesto Martín-Guillermo1,2, Israel Rivera-García2,3,4, Ana Álvarez-Alonso2,3
1Department of Otolaryngology, Hospital Universitario Central de Asturias, Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
Abstract:
Background: Human papillomavirus (HPV)-unrelated oropharyngeal squamous cell carcinoma (OPSCC) is a clinically aggressive disease characterized by poor outcomes and limited prognostic biomarkers. The Hippo-YAP pathway has emerged as a key regulator of tumorigenesis in epithelial cancers, although its role in OPSCC remains incompletely defined. Methods: We conducted a retrospective study including 215 patients with HPV-negative OPSCC treated surgically with curative intent. Tissue microarrays were constructed, and immunohistochemical analysis of YAP1 and TAZ expression was performed. Associations with clinicopathological variables, disease-free survival (DFS) and disease-specific survival (DSS) were assessed using univariable and multivariable analyses. Results: Nuclear and cytoplasmic YAP1 expression were detected in 53% and 85.6% of tumors, respectively. Both nuclear and cytoplasmic YAP1 expression were significantly associated with reduced DFS (p = 0.019 and p = 0.004, respectively) and DSS (p = 0.01 and p = 0.006, respectively). Multivariable analysis identified nodal involvement (HR = 1.64, p = 0.023) and nuclear YAP1 expression (HR = 1.65, p = 0.004) as independent predictors of DFS, and advanced tumor stage (HR = 1.57, p = 0.038), nodal involvement (HR = 2.34, p < 0.001), and nuclear YAP1 expression (HR = 1.78, p = 0.002) as independent predictors of DSS. In contrast, nuclear TAZ expression was observed at a lower frequency (14.5%) and showed no significant association with clinical parameters or survival outcomes. Conclusions: YAP1 expression, particularly its nuclear activated form, emerges as an independent poor prognostic factor in HPV-negative OPSCC, whereas nuclear TAZ expression was rather infrequent and showed no clinical relevance. These findings highlight the importance of Hippo pathway dysregulation in this tumor subtype and suggest the potential of YAP1 as both a prognostic biomarker and a therapeutic target.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
